-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
U.S. Stem Cell, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2017 to Q4 2022.
- U.S. Stem Cell, Inc. Operating Margin for the quarter ending December 31, 2022 was -2.1K %, a 97.1% decline year-over-year.
- U.S. Stem Cell, Inc. annual Operating Margin for 2022 was -2.1K %, a 97.1% decline from 2021.
- U.S. Stem Cell, Inc. annual Operating Margin for 2021 was -1.06K %, a 22.8% decline from 2020.
- U.S. Stem Cell, Inc. annual Operating Margin for 2020 was -866 %, a 679% decline from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)